GlaxoSmithKline plc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other
pharmaceutical manufacturers in Europe:
sales of 35.02 billion Euro [US$40.39 billion]
of which 48%
was Pharmaceuticals & Biological Products),
(49.16 billion Swiss Francs [US$50.26 billion]
of which 66%
was Innovative Medicines), and
based in France
(36.20 billion Euro [US$41.76 billion]
of which 83%
During the year ended December of 2017, sales at
GlaxoSmithKline plc were £30.19 billion (US$38.70 billion).
increase of 8.2%
versus 2016, when the company's sales were £27.89 billion.
This was the third consecutive year of growth at GlaxoSmithKline plc.
Sales of Vaccines saw an increase
12.4% in 2017, from
£4.59 billion to £5.16 billion.